Graymatter Labs

Graymatter Labs, based in the US, specializes in cognitive enhancement products, focusing on plant-based supplements designed to enhance mental clarity and reduce stress, primarily through their flagship product, Bright Mind. Founded in 2021 in Chicago, US, Graymatter Labs focuses on cognitive enhancement solutions. The company has engaged in one deal, raising USD 1. 3 mn in Seed funding on November 6, 2025, co-led by Venrex and APEX Capital with participation from Palette Ventures.

The total amount raised by the company stands at USD 1. 3 mn. Graymatter Labs specializes in cognitive enhancement products, primarily through its flagship offering, Bright Mind. This plant-based supplement aims to improve cognitive functionality by combining nootropics and adaptogens, providing users with increased concentration, reduced stress levels, and enhanced mood balance.

Bright Mind is designed to address common issues such as mental fatigue, ADHD, and distractions, making it suitable for professionals, athletes, and anyone seeking improved mental clarity in high-pressure situations. The product includes a diverse blend of 27 active ingredients grouped into four functional blends: energy fuel, cognitive support, eye protection, and stress management. These products are marketed primarily to customers in the United States and select international markets, appealing to a wide demographic that includes health-conscious individuals and those in demanding work environments. Graymatter Labs utilizes a subscription-based revenue model, allowing consumers to receive their products at a discounted rate and with the convenience of regular deliveries.

Customers can subscribe to receive Bright Mind at a lower cost per serving, fostering long-term engagement and loyalty. The pricing structure includes a 50% discount on the first order and a monthly subscription plan that offers additional savings, ensuring accessibility for a broader customer base. This model not only facilitates direct-to-consumer transactions but also enables the company to cultivate a steady revenue stream. Graymatter Labs also offers various products like travel packs and branded merchandise, further diversifying its revenue sources while reinforcing its brand presence in the cognitive health market.

In November 2025, Graymatter Labs raised USD 1. 3 mn in Seed funding, which will be allocated towards expanding staff and developing additional plant-based nootropic products. The company aims to design and launch new products targeting specific cognitive health needs, with potential releases planned for 2026. Additionally, Graymatter Labs is exploring expansion into international markets, broadening its reach by targeting Europe and Asia by the end of 2026.